ḥeleḳ 1. Me-ot [alef] ʻad ot [lamed] --ḥeleḳ 2. Me-ot [kaf] ʻad ot [taṿ].

sefer ḳeṭan ha-kamut ṿe-rav ha-eikhut kolel ʻinyene musar ṿe-hadrakhah be-ʻavodat ha-shem yitbarakh ṿe-hanhagot ṭovot...be-tosefet tsiyune marʼeh meḳomot mi-tanakh ume-ḥazal.

[1] Elul. Yamim Noraʼim. Sukot -- [2] Pesaḥ. Shevuʻot. Galut u-geʼulot. Ḥanukah. Purim.

[1] Elul. Yamim Noraʼim. Sukot -- [2] Pesaḥ. Shevuʻot. Galut u-geʼulot. Ḥanukah. Purim.

We examine ethical considerations in access to facial transplantation (FT), with implications for promoting health equity. As a form of vascularised composite allotransplantation, FT is still considered innovative with a relatively low volume of procedures performed to date by a small number of active FT programmes worldwide. However, as numbers continue to increase and institutions look to establish new FT programmes, we anticipate that attention will shift from feasibility towards ensuring the benefits of FT are equitably available to those in (...) need. This manuscript assesses barriers to care and their ethical implications across a number of considerations, with the intent of mapping various factors relating to health equity and fair access to FT. Evidence is drawn from an evolving clinical experience as well as published scholarship addressing several dimensions of access to FT. We also explore novel concerns that have yet to be mentioned in the literature. (shrink)